Beijing Inno Medical Technology

Beijing Inno-Molecular Technology (Innotek) is a leading Chinese biotechnology company specializing in the research, development, and manufacturing of in vitro diagnostic (IVD) solutions. The company focuses on Point-of-Care Testing (POCT) reagents and instruments, particularly for respiratory, gastrointestinal, and infectious diseases. Innotek gained significant prominence for its rapid diagnostic kits for SARS-CoV-2 and its multi-pathogen respiratory panels. Its product portfolio spans various technological platforms, including immunochromatography, molecular diagnostics, and fluorescence immunoassay. The company is publicly listed on the Shanghai Stock Exchange's STAR Market and serves both domestic and international healthcare markets.